Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | NAAA | Q02083 | 7/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2889371 | 0.87 | NAAA (0.42) | ALDH1A1NAAACYP3A4 | |
| SCHEMBL2889241 | 0.83 | ALDH1A1 (0.42) | ALDH1A1CYP1A2POLBCYP3A4CYP2C19 | |
| SCHEMBL5987814 | 0.83 | ALDH1A1 (0.42) | ALDH1A1CYP1A2POLBCYP3A4CYP2C19 | |
| SCHEMBL2889239 | 0.83 | ALDH1A1 (0.42) | ALDH1A1CYP1A2POLBCYP3A4CYP2C19 | |
| SCHEMBL2891648 | 0.82 | NAAA (0.39) | NAAA | |
| SCHEMBL2891153 | 0.81 | NAAA (0.40) | ALDH1A1NAAA | |
| SCHEMBL2887606 | 0.80 | KCNH2 (0.45) | ALDH1A1NAAA | |
| SCHEMBL2889489 | 0.79 | NPC1 (0.45) | ALDH1A1CYP1A2POLBCYP3A4CYP2C19 | |
| SCHEMBL2883791 | 0.74 | NAAA (0.41) | NAAA | |
| SCHEMBL2891502 | 0.74 | NAAA (0.42) | NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7781483-B2 | Benzopyran compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-08-24 | — | — | US | disclosed |
| US-20070299130-A1 | Benzopyran Compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070299130-A1 | Benzopyran Compound | NR0B1, CYP2B6, RYR2 | ALDH1A1 2971/4885NAAA 3819/4885CYP1A2 529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.